BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24418153)

  • 1. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms.
    Shroff S; Rashid A; Wang H; Katz MH; Abbruzzese JL; Fleming JB; Wang H
    Hum Pathol; 2014 Mar; 45(3):456-63. PubMed ID: 24418153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms.
    Gnerlich JL; Ding X; Joyce C; Turner K; Johnson CD; Chen H; Abood GJ; Pappas SG; Aranha GV
    Ann Surg Oncol; 2019 Feb; 26(2):628-634. PubMed ID: 30357576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
    Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
    Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SOX9 in intraductal papillary mucinous neoplasms of the pancreas.
    Meng F; Takaori K; Ito T; Masui T; Kawaguchi M; Kawaguchi Y; Uemoto S
    Pancreas; 2014 Jan; 43(1):7-14. PubMed ID: 24212241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas.
    Shimizu K; Itoh T; Shimizu M; Ku Y; Hori Y
    Pancreas; 2009 Nov; 38(8):e207-14. PubMed ID: 19786935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
    Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
    Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
    Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic neoplasia of the pancreas: pathology and biology.
    Adsay NV
    J Gastrointest Surg; 2008 Mar; 12(3):401-4. PubMed ID: 17957438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pdx1 expression in pancreatic precursor lesions and neoplasms.
    Park JY; Hong SM; Klimstra DS; Goggins MG; Maitra A; Hruban RH
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):444-9. PubMed ID: 21297446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
    Lüttges J; Zamboni G; Longnecker D; Klöppel G
    Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis.
    Tsuda M; Fukuda A; Roy N; Hiramatsu Y; Leonhardt L; Kakiuchi N; Hoyer K; Ogawa S; Goto N; Ikuta K; Kimura Y; Matsumoto Y; Takada Y; Yoshioka T; Maruno T; Yamaga Y; Kim GE; Akiyama H; Ogawa S; Wright CV; Saur D; Takaori K; Uemoto S; Hebrok M; Chiba T; Seno H
    J Clin Invest; 2018 Aug; 128(8):3475-3489. PubMed ID: 30010625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCD1 as a Novel Diagnostic Marker for Solid Pseudopapillary Neoplasm of the Pancreas.
    Liu YA; Liu Y; Tu J; Shi Y; Pang J; Huang Q; Wang X; Lin Z; Zhao Y; Wang W; Peng J; Wu W
    Am J Surg Pathol; 2024 May; 48(5):511-520. PubMed ID: 38567813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice.
    Kimura Y; Fukuda A; Ogawa S; Maruno T; Takada Y; Tsuda M; Hiramatsu Y; Araki O; Nagao M; Yoshikawa T; Ikuta K; Yoshioka T; Wang Z; Akiyama H; Wright CV; Takaori K; Uemoto S; Chiba T; Seno H
    Gastroenterology; 2018 Jul; 155(1):194-209.e2. PubMed ID: 29604291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms.
    Chang X; Yu C; Li J; Yu S; Chen J
    Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816
    [No Abstract]   [Full Text] [Related]  

  • 17. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
    Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
    Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].
    Ji Y; Tan YS; Zhu XZ; Zeng HY; Kuang TT; Jin DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):77-81. PubMed ID: 16630480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors.
    Keleg S; Titov A; Heller A; Giese T; Tjaden C; Ahmad SS; Gaida MM; Bauer AS; Werner J; Giese NA
    PLoS One; 2014; 9(6):e100178. PubMed ID: 24932730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.